Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Human Immunology|July 22, 2008
Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1alpha in activated human T lymphocytesDmitriy Lukashev, Michail SitkovskyFrontiers in Immunology|July 30, 2014
Extracellular adenosine-mediated modulation of regulatory T cellsAkio Ohta, Michail SitkovskyHandbook of Experimental Pharmacology|September 23, 2010
Methylxanthines, inflammation, and cancer: fundamental mechanismsAkio Ohta, Michail SitkovskyNature Reviews. Immunology|August 20, 2005
Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptorsMichail Sitkovsky, Dmitriy LukashevCurrent Opinion in Pharmacology|June 23, 2009
The adenosinergic immunomodulatory drugsAkio Ohta, Michail SitkovskyJournal of Molecular Medicine (Berlin, Germany)|January 22, 2013
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancerMichail Sitkovsky, Akio OhtaCurrent Opinion in Pharmacology|July 19, 2016
A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancerStephen M Hatfield, Michail SitkovskyOncoimmunology|November 21, 2015
Oxygenation to improve cancer vaccines, adoptive cell transfer and blockade of immunological negative regulatorsStephen M Hatfield, Michail SitkovskyNature Reviews. Rheumatology|November 11, 2016
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseasesBruce N Cronstein, Michail SitkovskyPurinergic Signalling|April 12, 2008
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapyDmitriy Lukashev, Michail Sitkovsky, Akio OhtaPageof 5